Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-30 Sale |
2024-02-02 4:57 pm |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
11,931 | $13.14 | $156,733 | 31,243 (Direct) |
View |
| 2023-12-06 Sale |
2023-12-08 6:15 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
82,648 | $9.9506 | $822,396 | 603,944 (Direct) |
View |
| 2023-10-16 Sale |
2023-10-18 4:21 pm |
Evolus Inc. | EOLS | Medytox Inc. Former 10% Owner |
1,690,663 | $7.5 | $12,679,973 | 3,381,326 (Direct) |
View |
| 2023-09-06 Sale |
2023-09-08 8:54 pm |
Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer |
3,178 | $9.7 | $30,827 | 113,368 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-16 8:25 pm |
Evolus Inc. | EOLS | Avelar Rui See Remarks |
2,211 | $10.27 | $22,707 | 353,386 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-16 8:25 pm |
Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer |
2,211 | $10.27 | $22,707 | 116,546 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-16 8:25 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
14,778 | $10.27 | $151,770 | 686,592 (Direct) |
View |
| 2023-08-15 Purchase |
2023-08-15 4:34 pm |
Evolus Inc. | EOLS | Malik Vikram Director |
174,967 | $7.41 | $1,296,505 | 298,548 (Direct) |
View |
| 2023-03-27 Sale |
2023-03-29 5:11 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
6,110 | $8.47 | $51,752 | 609,567 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-16 7:02 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
64,211 | $8.4689 | $543,797 | 615,677 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-16 7:01 pm |
Evolus Inc. | EOLS | Avelar Rui See Remarks |
14,906 | $8.4689 | $126,237 | 335,925 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 4:01 pm |
Evolus Inc. | EOLS | Alphaeon 1 LLC 10% Owner |
1,850,000 | $8.4 | $15,540,000 | 4,214,871 (Direct) |
View |
| 2023-02-07 Sale |
2023-02-08 8:10 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
2,187,511 | $8.5 | $18,593,844 | 5,071,989 (Direct) |
View |
| 2021-08-12 Purchase |
2023-02-06 4:18 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
37,043 | $11.04 | $408,839 | 7,259,500 (Indirect) |
View |
| 2023-01-20 Sale |
2023-02-06 4:18 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
37,043 | $11.04 | $408,955 | 7,259,500 (Indirect) |
View |
| 2022-10-06 Sale |
2022-10-07 4:12 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
38,304 | $8.9917 | $344,418 | 7,259,500 (Direct) |
View |
| 2022-10-05 Sale |
2022-10-06 4:18 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
6,848 | $8.95 | $61,290 | 7,297,804 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 4:10 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
97,000 | $10.29 | $997,778 | 7,304,652 (Direct) |
View |
| 2022-09-09 Purchase |
2022-09-13 5:57 pm |
Evolus Inc. | EOLS | HAYMAN ROBERT Director |
10,000 | $10.39 | $103,938 | 49,881 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-07 Option Award |
2024-02-09 6:37 pm |
N/A 2034-02-07 |
Evolus Inc. | EOLS | HAYMAN ROBERT Director |
15,841 | $0 | 74,599 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:37 pm |
N/A 2034-02-07 |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
15,841 | $0 | 47,084 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:37 pm |
N/A 2034-02-07 |
Evolus Inc. | EOLS | Malik Vikram Director |
15,841 | $0 | 291,391 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:36 pm |
N/A N/A |
Evolus Inc. | EOLS | Yamagishi-Dressler Tomoko Chief Marketing Officer |
70,108 | $0 | 70,108 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:36 pm |
N/A N/A |
Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer |
100,154 | $0 | 213,522 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:36 pm |
N/A N/A |
Evolus Inc. | EOLS | Avelar Rui See Remarks |
100,154 | $0 | 453,540 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:35 pm |
N/A N/A |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
451,413 | $0 | 1,055,357 (Direct) |
View |
| 2023-08-21 Option Award |
2023-08-23 8:07 pm |
N/A 2033-08-21 |
Evolus Inc. | EOLS | Yamagishi-Dressler Tomoko Chief Marketing Officer |
146,913 | $0 | 146,913 (Direct) |
View |
| 2023-08-14 Option Award |
2023-08-16 8:25 pm |
N/A N/A |
Evolus Inc. | EOLS | Avelar Rui See Remarks |
19,672 | $0 | 353,386 (Direct) |
View |
| 2023-08-14 Option Award |
2023-08-16 8:25 pm |
N/A N/A |
Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer |
19,672 | $0 | 116,546 (Direct) |
View |
| 2023-08-14 Option Award |
2023-08-16 8:25 pm |
N/A N/A |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
91,803 | $0 | 686,592 (Direct) |
View |
| 2023-08-11 Other |
2023-08-15 4:34 pm |
N/A N/A |
Evolus Inc. | EOLS | Malik Vikram Director |
22,998 | $0 | 298,548 (Direct) |
View |
| 2023-08-11 Other |
2023-08-15 4:32 pm |
N/A N/A |
Evolus Inc. | EOLS | BLANK SIMONE Director |
115,315 | $0 | 661,381 (Direct) |
View |
| 2023-08-11 Other |
2023-08-15 4:32 pm |
N/A N/A |
Evolus Inc. | EOLS | HAYMAN ROBERT Director |
584 | $0 | 59,342 (Direct) |
View |
| 2023-05-08 Option Award |
2023-05-09 6:21 pm |
N/A N/A |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
560,000 | $0 | 560,000 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:42 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | Stewart Brady Director |
20,082 | $0 | 56,590 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:42 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | HAYMAN ROBERT Director |
20,082 | $0 | 69,963 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:42 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | Malik Vikram Director |
20,082 | $0 | 89,374 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:41 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
20,082 | $0 | 54,963 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:41 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | BLANK SIMONE Director |
20,082 | $0 | 442,540 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:41 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | GILL DAVID N Director |
20,082 | $0 | 49,650 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:40 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | FARRELL PETER C Director |
20,082 | $0 | 64,963 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 7:25 pm |
N/A 2033-01-25 |
Evolus Inc. | EOLS | Avelar Rui See Remarks |
183,312 | $0 | 436,501 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 7:24 pm |
N/A 2033-01-25 |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
444,936 | $0 | 936,897 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 7:24 pm |
N/A 2033-01-25 |
Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer |
148,312 | $0 | 184,755 (Direct) |
View |